GENSTAR THERAPEUTICS CORP
10QSB, EX-27, 2000-08-04
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: GENSTAR THERAPEUTICS CORP, 10QSB, 2000-08-04
Next: VENDINGDATA CORP, SC 13D/A, 2000-08-04



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF GENSTAR CORPORATION AS OF AND FOR THE SIX MONTHS ENDED
JUNE 30, 2000.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               JUN-30-2000             JUN-30-1999
<CASH>                                      24,215,542                 921,994
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    1,507                 114,208
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                            24,311,204               1,045,663
<PP&E>                                       1,560,956                 726,489
<DEPRECIATION>                               (288,202)               (157,368)
<TOTAL-ASSETS>                              25,875,721               1,826,913
<CURRENT-LIABILITIES>                          984,013                 597,952
<BONDS>                                              0                       0
                                0                       0
                                         88                      88
<COMMON>                                        22,288                  12,104
<OTHER-SE>                                  19,898,516               (917,510)
<TOTAL-LIABILITY-AND-EQUITY>                25,875,721               1,826,913
<SALES>                                              0                       0
<TOTAL-REVENUES>                                73,133                  50,812
<CGS>                                                0                       0
<TOTAL-COSTS>                                5,060,682               1,553,010
<OTHER-EXPENSES>                               480,625                   8,743
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                            (51,961)               (348,890)
<INCOME-PRETAX>                            (4,558,885)             (1,842,345)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (4,558,885)             (1,842,345)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (4,558,885)             (1,842,345)
<EPS-BASIC>                                     (0.17)                  (0.20)
<EPS-DILUTED>                                   (0.17)                  (0.20)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission